Two Diseases-One Preclinical Treatment Targeting Glycogen Synthesis.
| Autor: | Gentry MS; Department of Molecular and Cellular Biochemistry, College of Medicine, University of Kentucky, Lexington, KY, USA. matthew.gentry@uky.edu., Markussen KH; Department of Molecular and Cellular Biochemistry, College of Medicine, University of Kentucky, Lexington, KY, USA., Donohue KJ; Department of Molecular and Cellular Biochemistry, College of Medicine, University of Kentucky, Lexington, KY, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics [Neurotherapeutics] 2022 Apr; Vol. 19 (3), pp. 977-981. Date of Electronic Publication: 2022 Apr 22. |
| DOI: | 10.1007/s13311-022-01240-9 |
| Databáze: | MEDLINE |
| Externí odkaz: |
|
Full text from SpringerLink